Target intelligence / Profile preview

Translocation associated membrane protein 2 (TRAM2)

Target
TRAM2
Molecular classification
Translocon component, Endoplasmic reticulum membrane protein, Ceramide-binding protein
01

Overview

Translocation associated membrane protein 2 (TRAM2) is a critical component of the endoplasmic reticulum (ER) translocon complex, a gated channel responsible for the translocation and proper processing of secretory and membrane proteins. TRAM2 is essential for type I collagen biosynthesis, particularly in cells transitioning to active collagen production, such as hepatic stellate cells and fibroblasts. Its C-terminal domain interacts with the ER Ca²⁺ pump SERCA2b, elevating local ER calcium concentration needed for collagen folding and assembly. TRAM2 also functions as a ceramide-binding protein, influencing the topology and translocation of specific proteins. Overexpression of TRAM2 is observed in several cancers, such as glioma and oral squamous cell carcinoma, where it promotes proliferation, invasion, metastasis, and poor clinical prognosis—often through activation of pathways like PI3K/AKT/mTOR and matrix metalloproteinases (MMPs). TRAM2 is thus implicated as a potential therapeutic target in cancer and fibrosis, while abnormal modulation may present risks for ER function, protein folding, and tissue homeostasis.

Other names
Translocating chain-associated membrane protein 2KIAA0057TRAM-like proteinTRAM2
02

Biological functions

Protein translocation across ER membraneCollagen type I biosynthesisRegulation of ER calcium concentration via SERCA2b couplingRegulation of protein folding and assemblyRegulated alternative translocation (RAT) of specific transmembrane proteinsModulation of PI3K/AKT/mTOR pathway
03

Disease associations

Cancer (including glioma and oral squamous cell carcinoma)Fibrosis-related processes (via collagen biosynthesis)Potential roles in ocular infectious diseases (based on disease associations in genetics databases)
04

Safety considerations

Possible risk of impaired collagen biosynthesis and extracellular matrix integrity if TRAM2 function is inhibitedPossible induction of ER stress upon abnormal expression, affecting cellular homeostasis
05

Biomarkers

Overexpression in cancer (glioma, oral squamous cell carcinoma) associated with malignancy, poor prognosis, and metastasis

Beyond the preview

Go deeper on Translocation associated membrane protein 2 (TRAM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Translocation associated membrane protein 2 (TRAM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call